The role of vitamin D in impaired fertility treatment

Neuroendocrinology Letters

Volumn 34, Issue 8, 2013, Pages 756-762

  Grzechocinska, Barbara ^a   Dabrowski, Filip A ^a   Cyganek, Anna ^a   Wielgos, Miroslaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

ART; Endometriosis infertility; In vitro fertilization; Infertility; Male infertility; Myoma infertility; Polycystic ovary syndrome; Premature ovary failure; Vitamin D

Indexed keywords

25 HYDROXYERGOCALCIFEROL; ANDROSTENEDIONE; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; FOLLITROPIN; INSULIN RECEPTOR; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; PARATHYROID HORMONE; SEX HORMONE BINDING PROTEIN; SPERM ANTIBODY; TESTOSTERONE; VITAMIN D; VITAMIN D BINDING PROTEIN;

ASTHENOSPERMIA; BONE DENSITY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; INFERTILITY THERAPY; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; MALE INFERTILITY; MYOMA; NIDATION; OLIGOSPERMIA; OVARIAN RESERVE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREMATURE OVARIAN FAILURE; REPRODUCTION; REVIEW; SPERMATOZOON COUNT; SYSTEMATIC REVIEW; UTERUS MYOMA; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

FEMALE; FERTILITY; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; PREGNANCY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84895783827     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Anifandis GM, Dafopoulos K, Messini Cl, Chalvatzas N, Liakos N, Pournaras S, Messinis IE (2010). Prognostic value of follicular fluid 25-OH vitamin D and glucose levels in the IVF outcome. Reprod Biol Endocrinol. 8:91.
2. Aquila S, Guido C, Middea E, Perrotta I, Bruno R, Pellegrino M, Andò S (2009). Human male gamete endocrinology: 1 alpha, 25-dihydroxyvitamin D3 (1,25(OH)2D3) regulates different aspects of human sperm biology and metabolism. Reprod Biol Endocrinol. 7:140. doi: 10.1186/1477-7827-7- 140.
3. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. (2006). Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline. J Clin Endocrinol Metab. 91:4237-4245 (Pubitemid 44833391)
4. Bomba-Opon D, Brawura-Biskupski-Samaha R, Kozlowski S, Kosinski P, Bartoszewicz Z, Bednarczuk T, Wielgos M (2013). First trimester maternal serum vitamin D and markers of preeclampsia. J Matern Fetal Neonatal Med. Sep [Epub ahead of print] PubMed PMID: 24050181.
5. Christakos S, Dhawan P, Benn B, Porta A, Hediger M, Oh GT, Jeung EB, Zhong Y, Ajibade D, Dhawan K, Joshi S (2007). Vitamin D: molecular mechanism of action.Ann NY Acad Sci. 1116: 340-348. (Pubitemid 350274347)
6. Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, Pittas AG, Boland R, Ferrucci L, Bikle DD (2013). Vitamin D: beyond bone. Ann N Y Acad Sci. 1287:45-58.
7. Di Rosa M, Malaguarnera G, De Gregorio C, Palumbo M, Nunnari G, Malaguarnera L (2012). Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell Immunol. 280(1): 36-43.
8. Firouzabadi RD, Rahmani E, Rahsepar M, Firouzabadi MM (2013). Value of follicular fluid vitamin D in predicting the pregnancy rate in an IVF program. Arch Gynecol Obstet. Jul 24. [Epub ahead of print].
9. Habib FK, Maddy SQ, Geliy KJ (1990). Characterisation of receptors for 1,25-dihydroxyvitamin D3 in the human testis. J Steroid Biochem. 35(2): 195-199. (Pubitemid 20067762)
10. Hammoud AO, Meikle AW, Peterson CM, Stanford J, Gibson M, Carrell DT (2012). Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J Androl. 14(6): 855-859.
11. Jenny A Visser, Frank H de Jong, Joop S E Laven, Axel P N (2006). Themmen Anti-Müllerian hormone: a new marker for ovarian function. Reproduction. 131:1-9.
12. K Evans, L Nguyen, J Chan, B A. Innes, J N. Bulmer, M Kilby, M Hewison (2006). Effects of 25-Hydroxyvitamin D3 and 1,25-Dihy-droxyvitamin D3 on cytokine production by human decidual cells. Biology of Reproduction. 75(6): 816-822. (Pubitemid 44845586)
13. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47.
14. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WHB (2011) . A validated model of serum anti-Müllerian hormone from conception to menopause. J. PLoS ONE. 6(7): e22024.
15. Luk J, Weisman Y, Harell A, Edelstein S, David M, Spirer Z, Golander A (1979). 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihy-droxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature. 281 (5729): 317-319. (Pubitemid 10225344)
16. Malloy PJ, Peng L, Wang J, Feldman D (2009). Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance MIS promoter: regulation of MIS expression by calcitriol in prostate cancer cells.Endocrinology. 150(4): 1580-1587.
17. Mellanby E (1919). An experimental investigation of rickets. Lancet. 1:407-412.
18. Merhi ZO, Seifer DB, Weedon J, Adeyemi O, Holman S, Anastos K, Golub ET, Young M, Karim R, Greenblatt R, Minkoff H (2012). Circulating vitamin D correlates with serum antimiillerian hormone levels In late-reproductive-aged women: Women's InteragencyHIV Study. Fertil Steril. 98(1): 228-234.
19. Nestler JE, Reilly ER, Cheang Kl, Bachmann LM, Downs RW Jr (2012) . A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. Trans Am Clin Climatol Assoc. 123: 209-19; discussion 219-220.
20. Ott J, Wattar L, Kurz C, et al (2012). Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study Eur J Endocrinol. 166:897-902.
21. Ozkan S, Jindal S, Greenseid K, Shu J, Zeitlian G, Hickmon C, Pal L (2010). Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil Steril. 94(4): 1314-1319.
22. Paffoni A, Somigliana E, Vigano P, Benaglia L, Cardellicchio L, Pagliardini L, Papaleo E, Candiani M, Fedele L (2013). Vitamin D status in women with uterine leiomyomas. J Clin Endocrinol Metab. 98(8): E1374-1378.
23. Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, Seto-Young D (2010). Vitamin D regulates steroido-genesis and insulin-like growth factor binding protein-1 (IGFBP1) production in human ovarian cells. Horm Metab Res. 42(10): 754-757.
24. Patra SK, Nasrat H, Goswaml B, Jain A (2012). Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr. 6(3): 146-9.
25. Pérez-Fernandez R, Alonso M, Segura C, Muñoz I, García-Caballero T, Diguez C (1997). Vitamin D receptor gene expression in human pituitary gland. Life Sci. 60(1): 35-42. (Pubitemid 27025682)
26. Płudowski P, Karczmarkiewicz E, Bayer M, Carter G et al. (2013). Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe - recommended vitamin D intakes in general population and group at risk of vitamin D deficiency. Endokrynol Pol. 64(4): 319-327.
27. Poreba R, Drews K, Karowicz-Biliñska A, Oszukowski P, Pawelczyk L, Radowicki S, Spaczyñski M, Szczapa J (2011). Zespotu Ekspertów Polskiego Towarzystwa Ginekologicznego. [Expert review of Polish Gynecological Society regarding micronutrient supplementation in pregnancy]. Ginekol Pol. 82(7): 550-553.
28. Prosser DE, Jones G (2004). Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci. 29(12): 664-673. (Pubitemid 39491265)
29. Ramlau-Hansen CH, Moeller UK, Bonde JP, Olsen J, Thulstrup AM (2011). Are serum levels of vitamin D associated with semen quality? Results from a cross-sectional study in young healthy men. Fertil Steril. 95(3): 1000-1004.
30. Ricardo Azziz (2006). Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature. J Clinical Endocrinol Metabolism. 91 (3): 781-785.
31. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL (2012). IOM committee members respond to Endocrine Society vitamin D guideline. Clin Endocrinol Metab. 97(4): 1146-1152.
32. Rudick B, Ingles S, Chung K, Stanczyk F, Paulson R, Bendikson K (2012). Characterizing the influence of vitamin D levels on IVF outcomes. Hum Reprod. 27(11): 3321-3327.
33. Seifer DB, Maclaughlin DT (2007). Review Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical sig-nificance. Fertil Steril. 88(3): 539-46. (Pubitemid 47368260)
34. Seremak-Mrozikiewicz A, Drews K, Mrozikiewicz PM, Bartkowiak-Wieczorek J, Marcinkowska M, Wawrzyniak A, Slomski R, Kalak R, Czerny B, Horst-Sikorska W (2009). Correlation of vitamin D receptor gene VDR polymorphism with osteoporotic changes in Polish postmenopausal women. Neuro Endocrinol Lett. 30(4): 540-6.
35. Somigliana E, Panina-Bordignon P, Murone S, Di Lucia P, Vercellini P, Vigano P (2007). Vitamin D reserve is higher in women with endometriosis. Hum Reprod. 22(8): 2273-2278. (Pubitemid 47241875)
36. Thomson RL, Spedding S, Buckley JD (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 77(3): 343-50.
37. Torrealday S, Neal Perry G, Pal L (2012). Relevance of vitamin D in reproduction. Hum Reprod. 27(10): 3015-3027.
38. Troszyński M (2009). Cwiczenia Potoznicze [(Obstetric textbok -in Polish)]. Warszawa: PZWL.
39. Van Etten E, Decallonne B, Verlinden L, Verstuyf A, Bouillon R, Mathieu C (2003). Analogs of 1 alpha, 25-dihydroxyvitamin D3 as pluripotent immunomodulators. J Cell Biochem. 88(2): 223-226. (Pubitemid 36119890)
40. Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR, Obermayer-Pietsch B (2009). Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 161(4): 575-82.
41. Yang B, Sun H, Wan Y, Wang H, Qin W, Yang L, Zhao H, Yuan J, Yao B (2012). Associations between testosterone, bone mineral density, vitamin D and semen quality in fertile and infertile Chinese men. Int J Androl. 35(6): 783-792.
42. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG, Kamaci M (2009). Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.Arch Gynecol Obstet. 280(4): 559-563.
43. Yu HM, Li XJ, Kadam AL, Cheng CY, Koide SS (1994). Human testis vitamin D Winding protein involved in infertility. Arch Androl. 33(2): 119-128. (Pubitemid 24297090)